Physician

Mark D Holm, MD

According to 2025 Medicare claims, Mark Holm, MD (NPI: 1831189240) practices endocrinology in the St. Cloud, MN market, with the plurality of this provider's patient population coming from Stearns, MN. This provider's primary affiliated billing organization is CENTRACARE CLINIC (NPI: 1407858020; TIN: 411806657) and primary practice location at 56303-5000. Holm is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), Caravan Collaborative Pathways (ACO ID: A4604), Aledade 103 Upper Midwest MSSP (ACO ID: A5003), Caravan Health ACO 50 LLC (ACO ID: A5160), Collaborative ACO 30, LLC (ACO ID: A5483), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Holm's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 463 traditional Medicare patients, billed 15,229 HCPCS/CPT codes, and received $173,515 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,939 prescription claims across 319 beneficiaries totaling $1,265,233 in drug costs, led by Ozempic (Semaglutide). DME data shows 288 claims. Open Payments data shows 23 records totaling $21,376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $37,243 to $173,515. Similarly, Part D prescription costs have risen steadily, from $924,392 to $1,265,233. For DME billing, reported payments moved sharply higher in recent years, from $2,527 to $74,120.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	373	6,141	$37,243
2016	394	9,404	$35,324
2017	437	9,025	$55,071
2018	459	10,596	$58,799
2019	611	14,418	$94,412
2020	649	15,450	$104,406
2021	571	16,306	$167,979
2022	575	19,342	$168,006
2023	546	16,529	$152,593
2024	463	15,229	$173,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	168	1,918	$924,392
2016	173	1,961	$895,598
2017	195	2,107	$987,908
2018	233	2,556	$1,417,009
2019	265	2,456	$1,300,632
2020	257	2,493	$1,280,213
2021	268	2,600	$1,285,273
2022	301	2,823	$1,468,550
2023	313	2,874	$1,421,928
2024	319	2,939	$1,265,233

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	55	209	$5,118
2016	51	206	$4,278
2017	30	145	$2,935
2018	55	203	$7,262
2019	54	296	$38,266
2020	45	271	$38,619
2021	38	296	$57,186
2022	38	337	$62,331
2023	40	389	$63,412
2024	40	288	$72,827

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	85	145	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	127	176	$79
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	134	155	$12
77080	Dxa bone density measurement of hip, pelvis, spine	78	78	$9
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	73	73	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	255	12,572	$403,178
Farxiga	Dapagliflozin Propanediol	137	8,510	$144,276
Kerendia	Finerenone	76	4,020	$80,188
Jardiance	Empagliflozin	56	4,331	$79,690
Rybelsus	Semaglutide	39	2,070	$59,524

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	26	114	$50,019
E0784	External ambulatory infusion pump, insulin	Y	N/R	33	$11,161
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	24	$5,501
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	35	$3,361
A4225	Supplies for external insulin infusion pump, syringe type cartridge, sterile, each	N	N/R	23	$1,864

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	23	$21,376	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark D. Holm, MD?

Tedicare shows public-source Medicare data for Mark D. Holm, MD (NPI 1831189240), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark D. Holm, MD have ACO affiliation data?

Mark D. Holm, MD is shown with ACO affiliation data for Central Minnesota ACO, LLC (MSSP, ACO ID A2844), Caravan Collaborative Pathways (MSSP, ACO ID A4604), Aledade 103 Upper Midwest MSSP (MSSP, ACO ID A5003), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Collaborative ACO 30, LLC (MSSP, ACO ID A5483), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark D. Holm, MD?

Mark D. Holm, MD is linked to CENTRACARE CLINIC (billing NPI 1407858020) in the available physician profile data.

Does Mark D. Holm, MD have Open Payments data?

Mark D. Holm, MD has 23 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.